Acute coronary syndrome in young adults: The Thai ACS registry

Journal of the Medical Association of Thailand

Volumn 90, Issue SUPPL 1, 2007, Pages 81-90

  Tungsubutra, Wiwun ^a   Tresukosol, Damras ^b   Buddhari, Wacin ^b   Boonsom, Watana ^c   Sanguanwang, Sopon ^d   Srichaiveth, Boonchu ^e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^c NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^d PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^e Bangkok Hospital Medical Center   (Thailand)

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Young adults

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; DATA BASE; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; REGISTER; RISK FACTOR; SMOKING; THAILAND; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; DATABASES AS TOPIC; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SMOKING; THAILAND; TREATMENT OUTCOME;

EID: 43849107489     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pasricha A, Batchelor W. When young hearts are broken: profiles of premature myocardial infarction. Am Heart J 2002; 143: 4-6.
2. Doughty M, Mehta R, Bruckman D, Das S, Karavite D, Tsai T, et al. Acute myocardial infarction in the young-the University of Michigan experience. Am Heart J 2002; 143: 56-62.
3. Choudhury L, Marsh JD. Myocardial infarction in young patients. Am J Med 1999; 107: 254-61.
4. Zimmerman FH, Cameron A, Fisher LD, Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 1995; 26: 654-61.
5. Chaithiraphan S, Sahasakul Y, Charoenchob N. Acute myocardial infarction in the young. J Med Assoc Thai 1985; 68: 190-7.
6. Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005; 149: 67-73.
7. Hong MK, Cho SY, Hong BK, Chang KJ, Mo-Chung I, Hyoung-Lee M, et al. Acute myocardial infarction in the young adults. Yonsei Med J 1994; 35: 184-9.
8. Warren SE, Thompson SI, Vieweg WV. Historic and angiographic features of young adults surviving myocardial infarction. Chest 1979; 75: 667-70.
9. Ismail J, Jafar TH, Jafary FH, White F, Faruqui AM, Chaturvedi N. Risk factors for non-fatal myocardial infarction in young South Asian adults. Heart 2004; 90: 259-63.
10. Al Khadra AH. Clinical profile of young patients with acute myocardial infarction in Saudi Arabia. Int J Cardiol 2003; 91: 9-13.
11. Berenson GS, Srinivasan SR, Bao W, Newman WP, III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-6.
12. Wolfe MW, Vacek JL. Myocardial infarction in the young. Angiographic features and risk factor analysis of patients with myocardial infarction at or before the age of 35 years. Chest 1988; 94: 926-30.
13. Dolder MA, Oliver MF. Myocardial infarction in young men. Study of risk factors in nine countries. Br Heart J 1975; 37: 493-503.
14. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992; 327: 669-77.
15. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-8.
16. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998; 339: 436-43.
17. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. N Engl J Med 1998; 338: 1498-505.
18. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med 1998; 338: 1488-97.
19. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-903.
20. Kofflard MJ, de Jaegere PP, van Domburg R, Ruygrok P, van den BM, Serruys PW, et al. Immediate and long-term clinical outcome of coronary angioplasty in patients aged 35 years or less. Br Heart J 1995; 73: 82-6.
21. Mukherjee D, Hsu A, Moliterno DJ, Lincoff AM, Goormastic M, Topol EJ. Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or =40 years old. Am J Cardiol 2003; 92: 1465-7.
22. Patel MR, Chen AY, Peterson ED, Newby LK, Pollack CV Jr, Brindis RG, et al. Prevalence, predictors and outcomes of patients with non-STsegment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. Am Heart J 2006; 152: 641-7.
23. Wang CH, Kuo LT, Hung MJ, Cherng WJ. Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease. Am Heart J 2002; 144: 275-81.
24. Harding MB, Leithe ME, Mark DB, Nelson CL, Harrison JK, Hermiller JB, et al. Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina. J Am Coll Cardiol 1992; 20: 107-11.
25. Diver DJ, Bier JD, Ferreira PE, Sharaf BL, McCabe C, Thompson B, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol 1994; 74: 531-7.
26. Moccetti T, Malacrida R, Pasotti E, Sessa F, Genoni M, Barlera S, et al. Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Data from the GISSI-2 database. Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). Arch Intern Med 1997; 157: 865-9.
27. Chouhan L, Hajar HA, Pomposiello JC. Comparison of thrombolytic therapy for acute myocardial infarction in patients aged < 35 and > 55 years. Am J Cardiol 1993; 71: 157-9.
28. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-4.